This article was originally published in The Gray Sheet
Executive SummaryAtlanta firm receives 510(k) clearance for its Salubria nerve cuff for use in peripheral nerve repair. The nerve cuff is designed to replace soft tissue in the body where peripheral nerves have been severed or damaged. R&D projects include use of Salubria as an alternative to total knee replacement for osteoarthritis or rheumatoid arthritis
You may also be interested in...
The Conservative Party's victory in the UK general election means the Brexit withdrawal deal will be able to pass. The UK will leave the EU by 31 January and enter a transition period during which medicines regulation will remain broadly unchanged.
The December 12 UK general election returned a Conservative majority, the scale or which few would have predicted. It means that the new government can press on with its plans for Brexit, the uncertainty now surrounding only when, not if.